4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001628280-26-074524
Chief Medical Officer returned 216,729.67 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SLONIN JONATHAN Chief Medical Officer | 2026-11-17 | Returned to the company | −216,729.67 | $36.50 | $7,910,633 | 0 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SLONIN JONATHAN Chief Medical Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −35,500 | $52.37 | 2030-07-02 | 35,500 | 0 | D: show line 2 in the form | ||
| SLONIN JONATHAN Chief Medical Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −14,137 | $60.96 | 2031-06-09 | 14,137 | 0 | D: show line 3 in the form | ||
| SLONIN JONATHAN Chief Medical Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −10,000 | $60.79 | 2031-08-03 | 10,000 | 0 | D: show line 4 in the form | ||
| SLONIN JONATHAN Chief Medical Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −24,800 | $59.39 | 2032-06-08 | 24,800 | 0 | D: show line 5 in the form | ||
| SLONIN JONATHAN Chief Medical Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −27,500 | $38.74 | 2033-06-14 | 27,500 | 0 | D: show line 6 in the form | ||
| SLONIN JONATHAN Chief Medical Officer | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −10,000 | $32.07 | 2034-01-03 | 10,000 | 0 | D: show line 7 in the form |
Loading xslF345X06/wk-form4_1794951344.xml…